Construction of MRI-Based Alzheimer's Disease Score Based on Efficient 3D Convolutional Neural Network: Comprehensive Validation on 7,902 Images from a Multi-Center Dataset

J Alzheimers Dis. 2021;79(1):47-58. doi: 10.3233/JAD-200830.

Abstract

Background: In recent years, many convolutional neural networks (CNN) have been proposed for the classification of Alzheimer's disease. Due to memory constraints, many of the proposed CNNs work at a 2D slice-level or 3D patch-level.

Objective: Here, we propose a subject-level 3D CNN that can extract the neurodegenerative patterns of the whole brain MRI and converted into a probabilistic Dementia score.

Methods: We propose an efficient and lightweight subject-level 3D CNN featuring dilated convolutions. We trained our network on the ADNI data on stable Dementia of the Alzheimer's type (sDAT) from stable normal controls (sNC). To comprehensively evaluate the generalizability of our proposed network, we performed four independent tests which includes testing on images from other ADNI individuals at various stages of the dementia, images acquired from other sites (AIBL), images acquired using different protocols (OASIS), and longitudinal images acquired over a short period of time (MIRIAD).

Results: We achieved a 5-fold cross-validated balanced accuracy of 88%in differentiating sDAT from sNC, and an overall specificity of 79.5%and sensitivity 79.7%on the entire set of 7,902 independent test images.

Conclusion: Independent testing is essential for estimating the generalization ability of the network to unseen data, but is often lacking in studies using CNN for DAT classification. This makes it difficult to compare the performances achieved using different architectures. Our comprehensive evaluation highlighting the competitive performance of our network and potential promise for generalization.

Keywords: 3D CNN; dementia of Alzheimer’s type (DAT); magnetic resonance imaging.

Publication types

  • Multicenter Study
  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Alzheimer Disease / diagnostic imaging*
  • Brain / diagnostic imaging*
  • Cognitive Dysfunction / diagnostic imaging*
  • Humans
  • Imaging, Three-Dimensional
  • Magnetic Resonance Imaging
  • Neural Networks, Computer*
  • Reproducibility of Results